Rapid Identification and Verification of Indirubin-Containing Medicinal Plants

Article English OPEN
Hu, Zhigang ; Tu, Yuan ; Xia, Ye ; Cheng, Peipei ; Sun, Wei ; Shi, Yuhua ; Guo, Licheng ; He, Haibo ; Xiong, Chao ; Chen, Shilin ; Zhang, Xiuqiao (2015)
  • Publisher: Hindawi Publishing Corporation
  • Journal: Evidence-based Complementary and Alternative Medicine : eCAM, volume 2,015 (issn: 1741-427X, eissn: 1741-4288)
  • Related identifiers: doi: 10.1155/2015/484670, pmc: PMC4451998
  • Subject: Other systems of medicine | Research Article | RZ201-999 | Article Subject

Indirubin, one of the key components of medicinal plants including Isatis tinctoria, Polygonum tinctorium, and Strobilanthes cusia, possesses great medicinal efficacy in the treatment of chronic myelocytic leukemia (CML). Due to misidentification and similar name, mater... View more
  • References (38)
    38 references, page 1 of 4

    Kantarjian, H. M., Deisseroth, A., Kurzrock, R., Estrov, Z., Talpaz, M.. Chronic myelogenous leukemia: a concise update. Blood. 1993; 82 (3): 691-703

    The Sixth Groups of Chinese Academy of Medical Sciences, null. The study on anti-leukemia of Dang Gui Lu Hui Wan. Bulletin of Medical Research. 1975 (7): 28-30

    Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., Eisenbrand, G., Meijer, L.. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nature Cell Biology. 1999; 1 (1): 60-67

    Nam, S., Buettner, R., Turkson, J., Kim, D., Cheng, J. Q., Muehlbeyer, S., Hippe, F., Vatter, S., Merz, K.-H., Eisenbrand, G., Jove, R.. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102 (17): 5998-6003

    Ma, M. Z.. The observation on curative effect of treating chronic myelogenous leukemia of Indigo Naturalis. Chinese Journal of Medicine. 1979; 4: 22-25

    Wu, G. Y., Fang, F. D., Liu, J. Z.. Research on the principle using indigo for the curative effect of chronic myelogenous leukemia (1): the influence on the DNA, RNA and protein synthesis of peripheral leukemia cells to the person. National Medical Journal of China. 1980; 60 (8): 451-454

    Wu, G. Y., Liu, J. Z., Fang, D. F., Zuo, J.. Research on the principle using indigo for the curative effect of chronic myelogenous leukemia: identification on the function and bond types of the combination of indigo and DNA. Science in China B. 1982 (5): 436-443

    Xiao, Z., Hao, Y., Liu, B., Qian, L.. Indirubin and Meisoindigo in the treatment of chronic myelogenous leukemia in China. Leukemia & Lymphoma. 2002; 43 (9): 1763-1768

    Marko, D., Schätzle, S., Friedel, A., Genzlinger, A., Zankl, H., Meijer, L., Eisenbrand, G.. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. British Journal of Cancer. 2001; 84 (2): 283-289

    Wu, Q. W., Ge, Z. L., Gao, Y., Zhang, L.. Inhibitory effect of indirubin on growth of some cancer cells and its mechanism. Tianjin Journal of Traditional Chinese Medicine. 2008; 25 (1): 55-58

  • Related Research Results (3)
  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark